956
Views
3
CrossRef citations to date
0
Altmetric
Case Report

A confusing manifestation: a case report of neurosarcoidosis presenting with confusion

, ORCID Icon, , &
Pages 363-367 | Received 17 Jul 2018, Accepted 02 Oct 2018, Published online: 11 Dec 2018

References

  • Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003 Jun 25;289(24):3300–3303.
  • Nozaki K, Judson MA. Neurosarcoidosis. Curr Treat Options Neurol. 2013 Aug;15(4):492–504.
  • Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013 Jun;26(3):307–313.
  • Ibitoye RT, Wilkins A, Scolding NJ. Neurosarcoidosis: a clinical approach to diagnosis and management. J Neurol. 2017 May;264(5):1023–1028.
  • Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016 Nov 15;16(1):220.
  • Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):297–304.
  • Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009 Jul;102(7):449–460.
  • Imran TF, Nizami S, Eyzner I, et al. Vertigo as a predominant manifestation of neurosarcoidosis. Case Rep Med. 2015 Apr;2(2015):397046.
  • Bihan H, Christozova V, Dumas J-L, et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine. 2007 Sep;86(5):259–268.
  • Wengert O, Rothenfusser-Korber E, Vollrath B, et al. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity. J Neurol Sci. 2013 Dec 15;335(1–2):124–130.
  • Brouwer MC, de Gans J, Willemse RB, van de Beek, D. Neurological picture. Sarcoidosis presenting with hydrocephalus. J Neurol Neurosurg Psychiatry. 2009 May;80(5):550–551.
  • Reda HM, Taylor SW, Klein CJ, et al. A case of sensory ataxia as the presenting manifestation of neurosarcoidosis. Muscle Nerve. 2011 Jun;43(6):900–905.
  • Zuniga G, Ropper AH, Frank J. Sarcoid peripheral neuropathy. Neurology. 1991 Oct;41(10):1558–1561.
  • Mitchell MS, Chalikonda MD, Kotler – the medicine forum MD, 2017. Neurosarcoidosis: granulomatous disease presenting with confusion and gait disturbance.jdc.jefferson.edu. [Internet]. 2017; Available from: http://jdc.jefferson.edu/tmf/vol18/iss1/9/
  • Bhat R, Ahad R, Ahmed I, et al.Neurosarcoidosis presenting as acute inflammatory polyneuropathy (P6.142). Neurology. 2016Apr5;8616 Suppl:Internet]. Available fromhttp://www.neurology.org/content/86/16_Supplement/P6.142.abstract
  • Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis–diagnosis and management. QJM. 1999 Feb;92(2):103–117.
  • Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol. 2006 Apr;253(4):488–495.
  • Kobak S, Yilmaz H, Sever F, et al. The prevalence of antinuclear antibodies in patients with sarcoidosis. Autoimmune Dis. 2014 Dec;17(2014):351852.
  • Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin North Am. 2017 Nov;43(4):593–606.
  • Tana C, Wegener S, Borys E, et al. Challenges in the diagnosis and treatment of neurosarcoidosis. Ann Med. 2015 Oct 15;47(7):576–591.
  • Flanagan EP, Kaufmann TJ, Krecke KN, et al. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016 Mar;79(3):437–447.